
PALVELLA THERAPEUTICS INC
PVLA · NASDAQ
Updated at 2026-10-18 00:11:26
- Today's High
- $127.27
- Today’s Low
- $118.22
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $127.27
- Previous Close
- $120.30
- Volume
- 179.48K
- Market Cap
- $1.73B
- P/E Ratio
- --
- EPS
- $-4.82
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 353 W. LANCASTER AVENUE, WAYNE, PA, UNITED STATES, 19087
- Country
- US
- Listing Date
- 2014-12-18
- Fiscal Year End
- December
- Shares Outstanding
- 14.34M
- CIK
- 0001583648
- Website
- palvellatx.com
Palvella Therapeutics, Inc. is an innovative biotechnology firm dedicated to developing transformative therapies for rare genetic disorders resulting from specific gene mutations. Its lead investigational product specifically targets pachyonychia congenita, directly addressing significant unmet medical needs within this niche patient population. With a strong focus on gene therapy and a strategic pipeline expansion, Palvella is poised to set new standards in the treatment of rare diseases, making it a compelling investment prospect for institutional investors looking to capitalize on growth in the biotech landscape.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$21.4M
2026-03-31
$14.85M
2025-12-31
$11.3M
2025-09-30
$10.17M
Net Income
2026-06-30
-$21.87M
2026-03-31
-$15.76M
2025-12-31
-$12.71M
2025-09-30
-$11.34M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-1.52
2026-03-31
$-1.20
2025-12-31
$-1.08
2025-09-30
$-1.03
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$21.56M
2026-03-31
-$17.8M
2025-12-31
-$10.97M
2025-09-30
$342K
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $21.4M | $14.85M | $11.3M | $10.17M |
| Net Income | -$21.87M | -$15.76M | -$12.71M | -$11.34M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-1.52 | $-1.20 | $-1.08 | $-1.03 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$21.56M | -$17.8M | -$10.97M | $342K |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.